The Lancet Haematology: Experts warn of stem cell underuse as transplants reach one million worldwide

However, the findings reveal striking variations between countries and regions in the use of this lifesaving procedure and high unmet need due to a chronic shortage of resources and donors that is putting lives at risk. HSCT is most often used to treat diseases of the blood and several types of cancer such as multiple myeloma or leukaemia .

http://ift.tt/1GLPrEN